These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30429167)

  • 21. Using the STROBE statement: survey findings emphasized the role of journals in enforcing reporting guidelines.
    Sharp MK; Bertizzolo L; Rius R; Wager E; Gómez G; Hren D
    J Clin Epidemiol; 2019 Dec; 116():26-35. PubMed ID: 31398440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observational studies in orthopaedic surgery: the STROBE statement as a tool for transparent reporting.
    Sheffler LC; Yoo B; Bhandari M; Ferguson T
    J Bone Joint Surg Am; 2013 Feb; 95(3):e14(1-12). PubMed ID: 23389794
    [No Abstract]   [Full Text] [Related]  

  • 23. Editor's choice: February 2021.
    Tovey D; Tugwell P
    J Clin Epidemiol; 2021 Feb; 130():A6-A7. PubMed ID: 33483005
    [No Abstract]   [Full Text] [Related]  

  • 24. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.
    von Elm E; Altman DG; Egger M; Pocock SJ; Gøtzsche PC; Vandenbroucke JP;
    Int J Surg; 2014 Dec; 12(12):1495-9. PubMed ID: 25046131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting.
    Pratt NL; Mack CD; Meyer AM; Davis KJ; Hammill BG; Hampp C; Setoguchi S; Raman SR; Chun DS; Stürmer T; Lund JL
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):9-17. PubMed ID: 31736248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
    Vandenbroucke JP; von Elm E; Altman DG; Gøtzsche PC; Mulrow CD; Pocock SJ; Poole C; Schlesselman JJ; Egger M;
    Int J Surg; 2014 Dec; 12(12):1500-24. PubMed ID: 25046751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers.
    Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA
    BMC Res Notes; 2015 Nov; 8():634. PubMed ID: 26526064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    Int J Surg; 2021 Apr; 88():105906. PubMed ID: 33789826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CONSORT 2010 Statement-unfinished update?
    Cals JW; van Amelsvoort LG; Kotz D; Spigt MG
    J Clin Epidemiol; 2011 Jun; 64(6):579-82. PubMed ID: 21208776
    [No Abstract]   [Full Text] [Related]  

  • 30. The STROBE statement and neuropsychology: lighting the way toward evidence-based practice.
    Loring DW; Bowden SC
    Clin Neuropsychol; 2014; 28(4):556-74. PubMed ID: 23356727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Online survey about the STROBE statement highlighted diverging views about its content, purpose, and value.
    Sharp MK; Glonti K; Hren D
    J Clin Epidemiol; 2020 Jul; 123():100-106. PubMed ID: 32259582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevating the quality of disability and rehabilitation research: mandatory use of the reporting guidelines: mandatory use of the reporting guidelines.
    Chan L; Heinemann AW; Roberts J
    Pediatr Phys Ther; 2014; 26(3):280-2. PubMed ID: 24979080
    [No Abstract]   [Full Text] [Related]  

  • 33. Guidelines for reporting histopathology studies.
    Knijn N; Nagtegaal ID
    J Clin Pathol; 2015 Feb; 68(2):173-4. PubMed ID: 25605774
    [No Abstract]   [Full Text] [Related]  

  • 34. Guidelines for good pharmacoepidemiology practice (GPP).
    Public Policy Committee, International Society of Pharmacoepidemiology
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):2-10. PubMed ID: 26537534
    [No Abstract]   [Full Text] [Related]  

  • 35. PRISMA 2020 statement: What's new and the importance of reporting guidelines.
    Sohrabi C; Franchi T; Mathew G; Kerwan A; Nicola M; Griffin M; Agha M; Agha R
    Int J Surg; 2021 Apr; 88():105918. PubMed ID: 33789825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the Use and Value of Reporting Guidelines in Health Professions Education Research.
    O'Brien BC; West CP; Coverdale JH; Durning SJ; Roberts LW
    Acad Med; 2020 Nov; 95(11):1619-1622. PubMed ID: 33109958
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial. EQUATOR - reporting guidelines for "Enhancing the QUality and Transparency Of health Research".
    Sweet JJ
    Clin Neuropsychol; 2014; 28(4):547-8. PubMed ID: 24983313
    [No Abstract]   [Full Text] [Related]  

  • 38. Hoping for a TREND toward PRISMA: the variety and value of research reporting guidelines.
    Kearney MH
    Res Nurs Health; 2014 Apr; 37(2):85-7. PubMed ID: 24619627
    [No Abstract]   [Full Text] [Related]  

  • 39. Routinely collected data and comparative effectiveness evidence: promises and limitations.
    Hemkens LG; Contopoulos-Ioannidis DG; Ioannidis JPA
    CMAJ; 2016 May; 188(8):E158-E164. PubMed ID: 26883316
    [No Abstract]   [Full Text] [Related]  

  • 40. Good reporting practices and the CONSORT.
    Lira RP; Arieta CE
    Arq Bras Oftalmol; 2012; 75(2):85-6. PubMed ID: 22760795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.